Physicians’ Practices in Diabetic Nephropathy in Primary Healthcare Centers in Jazan City, Saudi Arabia, 2023
1
Department of Family Medicine, Jazan Health Affairs, Ministry of Health, Jazan 82611, Saudi Arabia
2
Department of Family and Community Medicine, Faculty of Medicine, Jazan University, Jazan 82621, Saudi Arabia
*
Author to whom correspondence should be addressed.
Medicina 2024, 60(3), 372; https://doi.org/10.3390/medicina60030372
Submission received: 27 January 2024
/
Revised: 16 February 2024
/
Accepted: 20 February 2024
/
Published: 22 February 2024
(This article belongs to the Section Urology & Nephrology)
Abstract
:Background and Objectives: Diabetes is one of the most common diseases dealt with by physicians in primary healthcare centers (PHCs). The disease is associated with macrovascular and microvascular complications, especially in those with long disease duration and uncontrolled diabetic nephropathy, which is one of the most common microvascular complications among diabetic patients. This investigation assessed the practices of physicians working at PHCs in terms of diabetic nephropathy screening, management, and referral. Materials and Methods: This study is a cross-sectional investigation targeting physicians working at PHCs in the Jazan region of Saudi Arabia between March and August of 2023. Data were collected via a self-administered questionnaire, which was distributed via online platforms. The questionnaire included sections measuring physicians’ demographic data and associated factors regarding training, the availability of resources, and practices in diabetic nephropathy, including screening, management, and referral. Chi-squared tests were used to assess associations between the practices of physicians and the measured demographics. Result: A total of 234 physicians participated in the investigation. The median age of the participants was 35 years. The adherence level of practice toward diabetic nephropathy according to American Diabetes Association (ADA) guidelines ranged from 40 points (the highest adherence level of participants) to 19 points (the lowest adherence level of participants), with a median of 33 points. Higher adherence levels were noted among physicians in Saudi Arabia, physicians with higher education levels, physicians specializing as family physicians or diabetologists, physicians who reported attending online and on-site training at diabetic centers, physicians who reported continuous access to urine and serum creatinine tests, and physicians who reported continuous access to the American Diabetes Association guidelines (p < 0.05). Conclusions: There are several factors associated with the level of adherence in diabetic nephropathy practice, such as physicians’ education level, specialty, training, and access to guidelines. The findings suggest the need for more training for PHC physicians in the care of patients affected by or at risk of diabetic nephropathy.
1. Introduction
The countries of the Arab Gulf Cooperation Council are considered to be situated in one of the regions with a high prevalence of diabetes. According to the latest International Diabetes Federation report, the frequency rate of diabetes in these countries including the Kingdom of Saudi Arabia, Bahrain, Qatar, Oman, Kuwait, and the United Arab Emirates, all of which have similar frequency rates of diabetes, ranges from 8% to 22% [1]. Diabetic nephropathy is the leading cause of end-stage renal disease (ESRD) [2] and one of the microvascular complications of diabetes (especially uncontrolled), with long-term complications. Early screening, management, and intervention make a difference in clinical care [3].
Almost one-third of the Saudi Arabian population with type 2 diabetes has diabetic nephropathy. In 2011, it was estimated that 42.5% of ESRD cases in Saudi Arabia were related to diabetes, and the cost of dialysis in the country amounted to SR 173,784 (US 46,332) per patient per year [4].
A cross-sectional study published in 2023 included patients with type 2 diabetes mellitus who visited the diabetes clinics of primary healthcare centers (PHCs) of two National Guard hospitals in the Eastern Province of Saudi Arabia. The study included 935 patients with type 2 diabetes (54.1% females and 45.9% males). The research found that microvascular complications in this region were common in patients with type 2 DM. The prevalence of microvascular complications in DM was 55.1%. The most typical complications that patients experienced were nephropathy (80.2%), retinopathy (32.7%), and neuropathy (8.4%) [5].
Diabetic nephropathy is the leading cause of end-stage renal disease. It is one of the common microvascular complications of diabetes. The earliest change triggered by metabolic factors is mainly hyperglycemia [4], and hypertension is considered one of the risk factors [6].
Most patients with diabetes receive follow-up care in primary healthcare centers. It is very important to detect complications early by screening to prevent deterioration and advanced complications. Diabetic nephropathy is usually asymptomatic, and symptoms do not develop until patients progress to late-stage grade IV–V chronic kidney disease. The usual screening of diabetic nephropathy uses the albumin/creatinine ratio, which is normal at <30 mg. Microalbuminuria is indicated between 30–300 mg, and >300 mg indicates macroalbuminuria [7]. Calculating the glomerular filtration rate (GFR) is very important in the annual screening of patients with diabetes to detect the stage of kidney disease [4].
The pattern of diabetic nephropathy among non-insulin-dependent diabetic patients in Saudi Arabia is similar to that in the Western world. The duration of diabetes and hypertension is an important risk factor for diabetic nephropathy, and there is a good correlation between nephropathy and the degree of proteinuria [8]. A cross-sectional study of diabetes in Lebanon found that the prevalence of microvascular complications was 33% among diabetic patients [9]. Therefore, the screening and early detection of diabetic kidney disease is very important in practice to prevent progression to a late stage and the need for dialysis. When most patients with diabetes receive follow-up care in PHCs and are asymptomatic for diabetic kidney disease, especially in the early stage, they should be screened to address the problem from the beginning to prevent complications, irreversible damage, and the need for dialysis.
It is important to assess the degree of applying the established guidelines pertaining to diabetic nephropathy in real-life clinical settings in a country that has a high prevalence of diabetes and, subsequently, a high risk of development of diabetic nephropathy. This emphasizes the importance of establishing screening for diabetic nephropathy as an innovative indicator for the management of patients with diabetes and the prevention of the development of complications. This indicates the importance of enhancing the effectiveness of screening services in primary healthcare settings to enable the detection of diabetic nephropathy cases in the early stages. According to the ADA, screening for diabetic nephropathy should be initiated immediately at the time of diagnosis in patients with type two diabetes. In clinical settings where laboratory infrastructure required for assessment of the value of urinary albumin excretion (UAE) is not available, which is the case in many primary healthcare settings, it is recommended to establish screening for diabetic nephropathy via semiquantitative dipstick measurement of albuminuria as an alternative and to receive follow-up care in the form of confirmatory diagnostic and clinical testing [7]. This study aimed to assess the screening, referral, and management practices of primary healthcare physicians in diabetic nephropathy and assessment of factors associated with practice adequacy.
2. Materials and Methods
2.1. Study Design and Settings
This study was a cross-sectional investigation conducted in the Jazan region in southwestern Saudi Arabia. This study targeted physicians working at PHCs in the region. Data collection was performed between March and August of 2023. Approval to conduct this study was granted by the Jazan Ethics Committee (number 2333). An electronic consent form was completed by the physicians who agreed to participate in the investigation. Data collection was anonymous and did not include any identification data.
2.2. Data Collection Tool
Data were collected via a self-administered questionnaire. The questionnaire was composed of three main components measuring the demographics of the physicians, the availability of facilities and services needed for the management of patients with diabetic nephropathy, and their reported practices when being visited by a patient suffering from or at risk of developing diabetic nephropathy. The content on practices in diabetic nephropathy was constructed by consulting relevant literature on diabetic nephropathy [7,10].
The validity and reliability of the developed questionnaire were ensured by performing the following steps. First, after selecting items relevant to assessing the physicians’ practices concerning diabetic nephropathy, a panel of experts was formed, comprising consultants in nephrology and family medicine. The panel was requested to complete a content validation form and provide a scale concerning adherence to diabetic guideline levels in diabetic nephropathy practice [11]. This was followed by an assessment of the face validity of the questionnaire using a sample of 10 male and female physicians to test the clarity of the questionnaire and the time needed to complete it. Finally, the reliability of the questionnaire was tested using Cronbach’s alpha, providing a value of 0.719.
2.3. Data Collection Process
After developing the questionnaire and testing its validity and reliability, the questionnaire was converted into an electronic format using Google Forms, and a web link was generated to facilitate access to the questionnaire. To obtain this study’s sample, administrative approval was secured to facilitate access to the physicians’ communication channels, including work-related WhatsApp groups, and distribution of the questionnaire web link via the relevant PHC administrations, thus completing the identification and engagement phases of data collection. Physicians who provided informed consent electronically were granted access to the questionnaire. Those who completed the questionnaire were designated as recruited participants, thus completing the final stage of the data collection process.
2.4. Data Analysis
Data analysis was performed using a statistical package for social science software (version 25). A descriptive analysis was conducted using frequency and proportions for binary and categorical data, while means, medians, standard deviations, and interquartile ranges were used to summarize continuous data according to their distribution. The descriptive analysis was followed up by inferential statistics to assess factors associated with knowledge and practice in diabetic nephropathy among the participating physicians.
The inferential analysis was initiated by estimating the level of practice. In this investigation, 14 items were used to measure the physicians’ levels of practice regarding diabetic nephropathy. Each item was given a score of 1 if the physician selected and practiced it correctly. The completed items were added to provide a practice score. The median value of the scores was utilized as a cut-off point to classify each physician as having lower or higher adherence to diabetic guideline levels in diabetic nephropathy practice.
The Chi-squared or Fisher’s Exact tests were used to assess differences in practice according to the measured physicians’ characteristics. To enable cross-tabulation, continuous variables, such as age, were classified into two groups according to the median. Furthermore, to avoid the presence of empty cells, specialties were grouped according to physicians who were general practitioners, family physicians, or diabetologists. Additionally, education level was grouped according to physicians with a master’s degree or lower and those who were board-certified or held a Ph.D. A value of p < 0.05 was designated as statistically significant for the applied statistical test.
3. Results
The total number of physicians who agreed to participate in this study was 234. The demographic characteristics of the recruited physicians are displayed in Table 1. The mean age of the physicians was 35 years, with a mean experience length of 7 years. The proportion of male physicians was higher than female physicians 59%, while more than half of the sample were Saudi Arabian physicians (58%). The majority of the participants were Arabic speakers (86%). When the physicians were asked about their specialty, nearly half were general practitioners; the remaining physicians were family physicians, and only one was a diabetologist. Upon asking the physicians about their education level, more than half held a bachelor’s degree, and only 33% were board-certified.
Table 2 summarizes the reported availability of training, services, and resources needed to provide healthcare for patients with or at risk of diabetic nephropathy, according to the recruited sample of physicians. When the participants were asked whether they had received training in diabetes management, half of the sample reported they had received training, either on-site or virtually, while 35 physicians reported they had not received training in diabetes management. Only 30% of the physicians indicated they had received clinical training at a diabetes center, and fewer than 10% reported receiving clinical training at a nephrology clinic.
Table 3 displays the availability of services and resources in primary healthcare centers concerning the management of diabetic nephropathy as reported by the recruited physicians. When the physicians were asked about the availability of resources concerning the care of patients with or at risk of diabetic nephropathy, only 41% indicated that glycated hemoglobin tests were always available at their centers. Similarly, 70% of the physicians reported that urine analysis tests were always available in their centers, while only 44% reported having serum creatinine tests continually available. The majority of the physicians reported access to the Wasfaty service (85%), which is a service provided by the Saudi Arabia Ministry of Health to facilitate medication prescription services.
When the physicians were asked whether they benefit from the consultation services of other clinics, only 22% reported that they always have access to consultations with a specialist, only 19% reported having access to consultations with a nutritionist, and only 30% reported having access to consultations with a health coach. Finally, when the physicians were asked if they have access to clinical guidelines for the management of patients with diabetic nephropathy, more than half of the sample reported having continuous access to the ADA guidelines, while only 15% reported having continuous access to kidney disease improving global outcomes (KDIGO).
Table 4 summarizes the practices of physicians regarding diabetic nephropathy, including screening, management, and referral. The reported frequency of screening for diabetic nephropathy was as follows: when the participants were assessed on the performance of routine screening of diabetic nephropathy, 181 physicians (77.4%) said they perform annual screening, which is a good practice according to the recommendations. The reported usual start of screening of diabetic nephropathy in type 1 diabetes was as follows: 122 physicians (52.1%) perform screening 5 years after diagnosis, which is good practice since type 1 has a mostly acute onset with the start of complication delay so screening (according to recommendations) starts 5 years after diagnosis.
For type 2 diabetes, 177 physicians (75.6%) start screening for diabetic nephropathy at diagnosis, which is correct practice according to the recommendations. Since patients have type 2 diabetes for a long time before diagnosis, the recommendation is to start initial screening at diagnosis, in contrast to type 1, in which screening starts after 5 years. Regarding the method used to screen for diabetic nephropathy, 200 physicians (85.5%) use the albumin-to-creatinine ratio, which is recommended by the guidelines as a measure for screening diabetic nephropathy. The ADA creatinine ratio guidelines can be summarized as follows: microalbuminuria is indicated between 30–300 mg, and >300 mg indicates macroalbuminuria; if there is a positive result of albumin, conduct a second test to confirm the positive test and also check for other factors that cause high urine albumin, such as heavy exercise and high levels of protein and some herbal medicines.
The number of visits is determined according to the result of the screening test; when the result of the albumin to creatinine ratio is 300 mg/g creatinine and GFR ≥ 90 mL/min/1.73, 51 (21.8%) physicians schedule two appointments per year, which indicates high adherence according to the recommendations. When the result of the initial screening albumin to creatinine ratio is 300 mg/g and GFR = 30–60 mL/min/1.73, 100 (42.7%) physicians provide two appointments per year, which is recommended by the guidelines.
The second part of the assessment was practice in management. Among patients with type 2 diabetes with chronic kidney disease with GFR > 25 mL/min/1.73 and urinary albumin of 300 mg/g creatinine, 137 (73.9%) physicians prescribe patients empagliflozin, which is a good practice among patients with diabetic kidney disease to prevent and delay the progression of the disease. In patients with type 2 diabetes, chronic kidney disease, and risk of cardiovascular disease, the contraindication is to use a sodium–glucose transport inhibitor; only 61 physicians (26.1%) use finerenone, which is recommended to prevent and delay progression in kidney disease if an SGLT2 inhibitor is contraindicated.
After starting patients with diabetes on angiotensin-converting enzyme inhibitor (ACEI) drugs, when the serum creatinine increases by <30% without volume depletion, 141 (60.3%) physicians continue the same medication, which is good practice according to the recommendations. Among patients with diabetic kidney disease on dialysis, 54 physicians prescribe 0.8 g/kg body weight/day, which is good practice, and only 23 (9.8%) physicians recommend a high level of protein, which is recommended for patients on dialysis. Among patients with diabetes with proteinuria, for non-pregnant women, 192 physicians prescribe an ACE inhibitor, which is good practice and recommended for patients with proteinuria to prevent the progression of diabetic kidney disease.
The third part of the questionnaire assessed the practice of physicians in terms of referral. Among patients with diabetes with GFR < 30 mL/min/1.73 on two consecutive visits, 189 physicians refer the patient to a nephrologist, which is good practice and recommended for stage IV kidney disease.
Table 5 displays the factors associated with the level of adherence to clinical guidelines pertaining to the management of patients with or at risk of diabetic nephropathy among the recruited physicians. The adherence level in practice ranged from 40 (higher adherence of the participants) to 19 (lower adherence of the participants), with a median of 33; above 33 was considered a high level of adherence, and lower than 33 was considered a low level of adherence. Higher adherence levels were noted among Saudi Arabian physicians, physicians with high education levels, physicians specializing as family physicians or diabetologists, physicians who reported attending online and on-site training, and those who trained at a diabetes center (p < 0.05). Physicians who reported continuous access to urine analysis tests or serum creatinine tests were more likely to have higher adherence levels but with marginal levels of statistical significance (p = 0.059 and 0.051, respectively). Finally, physicians who reported having continuous access to the ADA guidelines were more likely to report higher adherence levels in comparison with other physicians without continuous access to those guidelines (p < 0.001).
4. Discussion
This investigation was a cross-sectional study that targeted physicians working in the Jazan region of Saudi Arabia to measure their practices in the management of diabetic nephropathy in PHC settings. Among the recruited sample of physicians, higher levels of adherence to the guidelines pertaining to the management of diabetic nephropathy were associated with the physicians’ education level, specialty, access to the relevant clinical guidelines, and receipt of relevant training. The availability of the infrastructure and services required for the management of patients at risk of or diagnosed with diabetic nephropathy was associated with the adherence level but at a smaller magnitude compared with the other measured factors.
Evidence concerning the adherence of primary healthcare physicians toward diabetic guidelines regarding the management of patients affected by or at risk of diabetic nephropathy in Saudi Arabia is lacking. Nonetheless, the findings of this investigation can be compared with those of similar international investigations. Physicians’ practices in diabetic nephropathy can be affected by multiple factors related to the training of physicians working in primary healthcare. This study found that physicians who had received training had high adherence to the guidelines on practice in diabetic nephropathy; this finding agrees with that of a similar cross-sectional study conducted among general physicians between 1 March 2015 and 30 September 2015, in Cotonou; it found a positive impact of continuing medical training focusing on attitudes and practices in diabetic nephropathy [12].
Our study found that resources include limited access to diabetic centers, consultation services, nutritionists, health coaches, and ADA guidelines; this finding agrees with that of a qualitative study involving five teaching hospitals in Iran, which found that inadequate physical resources negatively affected nurses’ quality of practice [13]. Also in agreement with this study, it was found that higher adherence is associated with the availability of resources, such as access to the ADA guidelines, and a slightly significant association was found regarding the presence of lab tests for kidney function. A specialty higher than a general practitioner was associated with high adherence to the diabetic nephropathy guidelines. The present study agreed with the finding of another study that good skills and excellence in practice increase with continued medical education and higher degrees of knowledge and specialty [14].
The majority of the physicians recruited in this study showed optimum adherence to the guidelines concerning the recommended interval for the routine screening of diabetic nephropathy. In a study published in 2014 that involved 54,670 patients with type 2 diabetes in Saudi Arabia, it was noted that the overall prevalence of diabetic nephropathy was 10.8%, indicating that the detected prevalence of diabetic nephropathy suggests a need for a screening program in the country [15]. Nonetheless, screening programs for diabetes and similar chronic non-communicable diseases in Saudi Arabia are currently lacking [16].
This study has multiple areas of strengths and weaknesses. The main strength of this study is related to its ability to reach a sample of primary healthcare physicians who are working in different sectors at a regional level, and to assess their adherence to established clinical guidelines in diabetic nephropathy management according to different demographic and working characteristics. The main weakness of this study is related to its dependence on reporting of the recruited physicians, especially concerning the availability of infrastructure pertaining to diabetic nephropathy management, which may subject the findings to measurement bias. Nonetheless, the findings of this investigation are similar to other studies conducted in national and international contexts, and it could be argued that this study has reasonable validity and generalizability to similar clinical settings. The findings of this study indicate the need to strengthen the role of continuous professional development to enhance the quality of care provided by primary healthcare physicians to patients at risk or suffering from diabetic nephropathy. Furthermore, the findings indicate the need to perform subsequent interventional studies to provide evidence concerning best-needed training approaches and educational methods to enhance the quality of care and the adherence level of physicians concerning the management of diabetic nephropathy guidelines.
5. Conclusions
Our paper presents findings concerning the degree of adherence to the established guidelines concerning diabetic nephropathy management in real-life clinical settings in a country that has a high prevalence of diabetes and, subsequently, a high risk of development of diabetic nephropathy. This study identified several factors associated with the level of adherence to the guidelines pertaining to the management of diabetic nephropathy, including physicians’ education level, specialty, access to the relevant clinical guidelines, and receipt of relevant training. The findings of this investigation suggest the need to provide more training for PHC physicians in the care of patients affected by or at risk of diabetes. Furthermore, enhanced access to the relevant guidelines is required for all physicians working in PHC settings. Additionally, this study emphasizes the importance of establishing screening for diabetic nephropathy as an innovative indicator to enable appropriate management of patients with diabetes and prevention of the development of complications such as diabetic nephropathy.
Author Contributions
A.J.A., A.Y.A., B.M.G. and I.M.G. contributed to data analysis and drafted or revised the article. The authors have agreed on the journal to which the article will be submitted, provided final approval of the version to be published, and agree to be accountable for all aspects of the work. All authors have read and agreed to the published version of the manuscript.
Funding
This research received no external funding.
Institutional Review Board Statement
This study was approved by the Research Ethics Committee of Jazan University, Saudi Arabia (IRB Approval number REC-44/02/298, date 5 April 2023).
Informed Consent Statement
Informed consent was obtained from all subjects involved in this study.
Data Availability Statement
The data presented in this study are available upon request from the corresponding author.
Acknowledgments
Data collection: Yahya Almalki, Majed Ghazwani, Rawan Alharbi, and Ibrahi Khlaf.
Conflicts of Interest
The authors declare no conflicts of interest.
References
- Aljulifi, M.Z. Prevalence and reasons of increased type 2 diabetes in Gulf Cooperation Council Countries. Saudi Med. J. 2021, 42, 481–490. [Google Scholar] [CrossRef] [PubMed]
- Tziomalos, K.; Athyros, V.G. Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis. Rev. Diabet. Stud. RDS 2015, 12, 110–118. [Google Scholar] [CrossRef] [PubMed]
- Gedebjerg, A.; Bjerre, M.; Kjaergaard, A.D.; Steffensen, R.; Nielsen, J.S.; Rungby, J.; Friborg, S.G.; Brandslund, I.; Thiel, S.; Beck-Nielsen, H.; et al. Mannose-binding lectin and risk of cardiovascular events and mortality in type 2 diabetes: A Danish cohort study. Diabetes Care 2020, 43, 2190–2198. [Google Scholar] [CrossRef] [PubMed]
- Al-Rubeaan, K.; Siddiqui, K.; Al-Ghonaim, M.A.; Youssef, A.M.; Alnaqeeb, D. The Saudi diabetic kidney disease study (SAUDI-DKD): Clinical characteristics and biochemical parameters. Ann. Saudi Med. 2018, 38, 526–536. [Google Scholar] [CrossRef] [PubMed]
- Alnaim, M.M.; Alrasheed, A.; Alkhateeb, A.A.; Aljaafari, M.M.; Alismail, A. Prevalence of microvascular complications among patients with type 2 diabetes mellitus who visited diabetes clinics in Saudi Arabia. Saudi Med. J. 2023, 44, 211–217. [Google Scholar] [CrossRef] [PubMed]
- Hu, F. Study on Risk Factors of Diabetic Nephropathy in Obese Patients with Type 2 Diabetes Mellitus. Int. J. Gen. Med. 2020, 13, 351–360. [Google Scholar] [CrossRef] [PubMed]
- Of, S.; Carediabetes, M. Disclosures: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022, 45, S256–S258. [Google Scholar] [CrossRef]
- Huraib, S.; Abu-aisha, H.; Sulimani, R.A. The Pattern of Diabetic Nephropathy among Saudi Patients with Noninsulin-Dependent Diabetes Mellitus. Ann. Saudi Med. 1995, 15, 120–124. [Google Scholar] [CrossRef] [PubMed]
- Dia, N.; Ferekh, S.; Jabbour, S.; Akiki, Z.; Rahal, M.; Khoury, M.; Akel, M. Knowledge, attitude, and practice of patients with diabetes towards diabetic nephropathy, neuropathy and retinopathy. Pharm. Pract. 2022, 20, 1–8. [Google Scholar] [CrossRef] [PubMed]
- Eknoyan, G.; Lameire, N.; Wheeler, D.C. Kidney Disease: Improving Global, Outcomes. KDIGO Clinical Practice Guideline on Diabetes Mangement in Chronic Kidney Disease. Kidneys 2019, 9, 221–233. [Google Scholar]
- Yusoff, M.S.B. ABC of Content Validation and Content Validity Index Calculation. Educ. Med. J. 2019, 11, 49–54. [Google Scholar] [CrossRef]
- Jacques, V.; Mauriac, A.T.; Leopold, A.B.; Sabi, A.K.; Ubald, A.; Vénérand, A.; François, D. Knowledge Attitude and Practice of General Physicians for Early Detection of Diabetic Nephropathy in Cotonou. Open J. Nephrol. 2016, 6, 122–131. [Google Scholar] [CrossRef]
- Rivaz, M.; Momennasab, M.; Yektatalab, S.; Ebadi, A. Adequate resources as essential component in the nursing practice environment: A qualitative study. J. Clin. Diagn. Res. 2017, 11, IC01–IC04. [Google Scholar] [CrossRef] [PubMed]
- Unger, J.P.; Morales, I.; De Paepe, P.; Roland, M. Integrating clinical and public health knowledge in support of joint medical practice. BMC Health Serv. Res. 2020, 20, 1073. [Google Scholar] [CrossRef]
- Al-Rubeaan, K.; Youssef, A.M.; Subhani, S.N.; Ahmad, N.A.; Al-Sharqawi, A.H.; Al-Mutlaq, H.M.; David, S.K.; AlNaqeb, D. Diabetic nephropathy and its risk factors in a society with a type 2 diabetes epidemic: A Saudi national diabetes registry-based study. PLoS ONE 2014, 9, e88956. [Google Scholar] [CrossRef] [PubMed]
- Gosadi, I.M. National screening programs in Saudi Arabia: Overview, outcomes, and effectiveness. J. Infect. Public Health 2019, 12, 608–614. [Google Scholar] [CrossRef] [PubMed]
Table 1.
Sociodemographic characteristics of 234 physicians working at primary healthcare centers in Jazan, Saudi Arabia.
Table 1.
Sociodemographic characteristics of 234 physicians working at primary healthcare centers in Jazan, Saudi Arabia.
| Variable | Frequency (Proportion) |
|---|---|
| Gender | |
| Male | 138 (59%) |
| Female | 96 (41%) |
| Nationality | |
| Saudi Arabian | 135 (57.7%) |
| Non-Saudi Arabian | 99 (42.3%) |
| Language | |
| Arabic | 202 (86.3%) |
| Non-Arabic Speaker | 32 (13.7%) |
| Specialty | |
| General practitioner | 122 (52.1%) |
| Family physician | 111 (47.4%) |
| Diabetologist * | 1 (0.4%) |
| Education level | |
| Bachelor degree | 123 (52.6%) |
| High diploma | 9 (3.8%) |
| Master | 17 (7.3%) |
| Board | 77 (32.9%) |
| PhD | 3 (1.3%) |
| Fellowship | 5 (2.1%) |
| Health sector | |
| Central | 45 (19.2%) |
| Middle | 38 (16.2%) |
| Western | 32 (13.7%) |
| Northern | 21 (9%) |
| Southern | 45 (19.2%) |
| Jabali | 25 (10.7%) |
| Bani Malik | 23 (9.8%) |
| Farasan | 5 (2.1%) |
* A diabetologist is a physician who is a holder of a postgraduate degree in internal medicine or family medicine and completed a fellowship program in diabetes management.
Table 2.
Receipt of training concerning diabetic nephropathy among 234 physicians working at primary healthcare centers in Jazan, Saudi Arabia.
Table 2.
Receipt of training concerning diabetic nephropathy among 234 physicians working at primary healthcare centers in Jazan, Saudi Arabia.
| Type of Training | Frequency (Proportion) |
|---|---|
| Receipt of training in diabetes management | |
| Yes, on-site | 34 (14.5%) |
| Yes, online | 47 (20.1%) |
| Yes, both on-site and online | 118 (50.4%) |
| None | 35 (15%) |
| Receipt of clinical training at a diabetic center | 70 (29.9%) |
| Receipt of clinical training in nephrology | 23 (9.8%) |
| Receipt of practical training on GFR measurement | 181 (77.4%) |
GFR: glomerular filtration rate.
Table 3.
Availability of services and resources in primary healthcare centers concerning management of diabetic nephropathy as reported by 234 physicians working at primary healthcare centers in Jazan, Saudi Arabia.
Table 3.
Availability of services and resources in primary healthcare centers concerning management of diabetic nephropathy as reported by 234 physicians working at primary healthcare centers in Jazan, Saudi Arabia.
| Availability of Resources: Frequency (Proportion) | Always | Sometimes | Never |
|---|---|---|---|
| HGA1c test | 96 (41%) | 132 (56.4%) | 6 (2.6%) |
| Urine analysis test (proteinuria) | 164 (70.1%) | 60 (25.6%) | 10 (4.3%) |
| Serum creatinine level test | 103 (44%) | 92 (39.3%) | 39 (16.7%) |
| Access to Wasfaty services * | 200 (85.5%) | 27 (11.5%) | 7 (3%) |
| Access to consultation services | 51 (21.8%) | 114 (48.7%) | 69 (29.5%) |
| Access to a nutritionist | 44 (18.8%) | 98 (41.9%) | 92 (39.3%) |
| Access to a health coach | 72 (30.8%) | 93 (39.7%) | 69 (29.5%) |
| Access to ADA guidelines | 133 (56.8%) | 54 (23.1%) | 47 (20.1%) |
| Access to KDIGO guidelines | 35 (15%) | 79 (33.8%) | 120 (51.3%) |
* Wasfaty is an electronic medical service that is provided by the Saudi Arabia Ministry of Health to facilitate prescribing medication via a paperless format.
Table 4.
Reported practices among 234 physicians working at primary healthcare centers in Jazan, Saudi Arabia, concerning the care of patients with or at risk of diabetic nephropathy.
Table 4.
Reported practices among 234 physicians working at primary healthcare centers in Jazan, Saudi Arabia, concerning the care of patients with or at risk of diabetic nephropathy.
| Statement | Frequency [Proportion] |
|---|---|
| The frequency of performing routine screening for diabetic nephropathy is: | |
| Three times/year | 9 (3.8%) |
| Twice/year | 44 (18.8%) |
| Annually * | 181 (77.4%) |
| Initiation of screening of diabetic nephropathy in type 1 DM is: | |
| Initially at diagnosis | 81 (34.6%) |
| 1 year after diagnosis | 31 (13.2%) |
| 5 years after diagnosis * | 122 (52.1%) |
| Initiation of screening of diabetic nephropathy in type 2 DM is: | |
| 5 years after diagnosis | 25 (10.7%) |
| 1 year after diagnosis | 32 (13.7%) |
| Initially at diagnosis * | 177 (75.6%) |
| The utilized method for screening diabetic nephropathy is: | |
| Renal ultrasound | 6 (2.6%) |
| HGA1c | 28 (12%) |
| Albumin/creatinine ratio * | 200 (85.5%) |
| Frequency of follow-up visits among patients with urinary albumin = 300 mg/g creatinine and GFR ≥ 90 mL/min/1.73: | |
| Annually | 98 (41.9%) |
| Three times per year | 85 (36.3%) |
| Twice annually * | 51 (21.8%) |
| Frequency of follow-up visits among patients with urinary albumin = 300 mg/g creatinine and GFR = 30–60 mL/min/1.73: | |
| Annually | 29 (12.4%) |
| Three times per year | 105 (44.9%) |
| Twice annually * | 100 (42.7%) |
| Utilized medication for patients diagnosed with type 2 diabetes, chronic kidney disease eGFR > 25 mL/min/1.37, and urinary albumin = 300 mg/g creatinine: | |
| Metformin | 17 (7.3%) |
| Sitagliptin | 44 (18.8%) |
| Empagliflozin * | 173 (73.9%) |
| Utilized medication for patients diagnosed with type 2 diabetes, chronic kidney disease, risk of cardiovascular disease, and contraindication to use an SGLT2 inhibitor: | |
| Captopril | 85 (36.3%) |
| Valsartan | 88 (37.6%) |
| Finerenone * | 61 (26.1%) |
| Practices concerning a patient who started on ACEI/ARBs, with serum creatinine increasing by <30% without volume depletion: | |
| To stop medication and change to another class | 79 (33.8%) |
| To stop without adding another class | 14 (6%) |
| To continue the same medication * | 141 (60.3%) |
| The prescribed amount of protein prescribed for diabetic kidney disease patients on dialysis is: | |
| 0.7 g/kg of body weight/day | 41 (17.5%) |
| 0.6 g/kg of body weight/day | 139 (59.4%) |
| 0.8 g /kg of body weight/day * | 54 (23.1%) |
| Medication prescribed for diabetic, non-pregnant women, with proteinuria: | |
| Thiazide diuretic | 18 (7.7%) |
| Beta blocker | 24 (10.3%) |
| ACE inhibitor * | 192 (82.1%) |
| The level of protein intake advised for patients with diabetes and stage 5 chronic kidney disease on dialysis is: | |
| Low level of protein | 166 (70.9%) |
| Medium level of protein | 45 (19.2%) |
| High level of protein * | 23 (9.8%) |
| Practices concerning diabetic nephropathy patients with eGFR < 30 mL/min/1.73 on two consecutive visits are to: | |
| Schedule one visit/year to measure GFR | 19 (8.1%) |
| Consult internal medicine without a referral | 26 (11.1%) |
| Refer to a nephrologist * | 189 (80.8%) |
| Practices concerning a patient with rapid progressive kidney disease are: | |
| Follow up in PHC without a referral | 8 (3.4%) |
| Consult internal medicine without a referral | 22 (9.4%) |
| Refer to a nephrologist * | 204 (87.2%) |
* Adequate practices.
Table 5.
Factors associated with the practices of 234 physicians working at primary healthcare centers in Jazan, Saudi Arabia, concerning the care of patients with or at risk of diabetic nephropathy.
Table 5.
Factors associated with the practices of 234 physicians working at primary healthcare centers in Jazan, Saudi Arabia, concerning the care of patients with or at risk of diabetic nephropathy.
| Measured Characteristics | Practice Adequacy: Frequency (Proportions) | p Value | |
|---|---|---|---|
| High Adherence | Low Adherence | ||
| Gender * | 0.421 | ||
| Male | 85 (61.2%) | 53 (38.4%) | |
| Female | 54 (56.2%) | 42 (43.8%) | |
| Nationality * | 0.022 | ||
| Saudi Arabian | 89 (65.9%) | 46 (34.1%) | |
| Non-Saudi Arabian | 50 (50.5%) | 49 (49.5%) | |
| Language * | 0.252 | ||
| Arabic | 123 (60.9%) | 79 (39.1%) | |
| Non-Arabic speaker | 16 (50%) | 16 (50%) | |
| Education * | <0.001 | ||
| Bachelor, high diploma, master | 73 (49%) | 76 (51%) | |
| Board, PHD, fellowship | 66 (77.6%) | 19 (22.4%) | |
| Specialty * | <0.001 | ||
| GP | 52 (42.6%) | 70 (57.4%) | |
| Family medicine or diabetologist | 87 (77.7%) | 25 (22.3%) | |
| Receipt of training in diabetes management * | 0.011 | ||
| Yes, on-site | 19 (55.9%) | 15 (44.1%) | |
| Yes, online | 22 (46.8%) | 25 (53.2%) | |
| Yes, both online and on-site | 82 (69.5%) | 36 (30.5%) | |
| None | 16 (45.7%) | 19 (54.3%) | |
| Receipt of clinical training at a diabetic center * | 0.020 | ||
| Yes | 50 (71.4%) | 20 (28.6%) | |
| No | 89 (54.3%) | 75 (45.7%) | |
| Receipt of clinical training in nephrology * | 0.506 | ||
| Yes | 12 (52.2%) | 11 (47.8%) | |
| No | 127 (60.2%) | 84 (39.8%) | |
| Receipt of practical training on GFR measurement * | 0.025 | ||
| Yes | 115 (63.5%) | 66 (36.5%) | |
| No | 24 (45.3%) | 29 (54.7%) | |
| Availability of HGA1c test ** | 0.009 | ||
| Always | 57 (59.4%) | 39 (40.6%) | |
| Sometimes | 82 (62.1%) | 56 (37.9%) | |
| Never | 0 (0%) | 6 (100%) | |
| Availability of urine analysis test ** | 0.061 | ||
| Always | 104 (63.4%) | 60 (36.6%) | |
| Sometimes | 32 (53.3%) | 28 (46.7%) | |
| Never | 3 (30%) | 7 (70%) | |
| Availability of Serum creatinine level * | 0.051 | ||
| Always | 68 (66%) | 35 (34%) | |
| Sometimes | 54 (58.7%) | 38 (41.3%) | |
| Never | 17 (43.6%) | 22 (56.4%) | |
| Access to Wasfaty services ** | 0.229 | ||
| Always | 123 (61.5%) | 77 (38.5%) | |
| Sometimes | 12 (44.4%) | 15 (55.6%) | |
| Never | 4 (57.1%) | 3 (42.9%) | |
| Access to consultation services * | 0.299 | ||
| Always | 35 (68.5%) | 16 (31.4%) | |
| Sometimes | 62 (54.4%) | 52 (54.6%) | |
| Never | 42 (60.9%) | 27 (39.1%) | |
| Access to nutritionist * | 0.444 | ||
| Always | 27 (61.4%) | 17 (38.6%) | |
| Sometimes | 62 (63%) | 36 (36.7%) | |
| Never | 50 (54.3%) | 42 (45.7%) | |
| Access to a health coach * | 0.597 | ||
| Always | 41 (56.9%) | 31 (43.1%) | |
| Sometimes | 59 (63.4%) | 34 (36.6%) | |
| Never | 39 (56.5%) | 30 (43.5%) | |
| Access to KDIGO guidelines * | 0.426 | ||
| Always | 24 (68.6%) | 11 (31.4%) | |
| Sometimes | 44 (55.7%) | 35 (44.3%) | |
| Never | 71 (59.2%) | 49 (40.8%) | |
| Access to ADA guidelines * | <0.001 | ||
| Always | 96 (72.2%) | 37 (27.8%) | |
| Sometimes | 21 (38.9%) | 33 (61.1%) | |
| Never | 22 (46.8%) | 25 (53.2%) | |
* Chi-Square test. ** Fisher’s Exact test.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
MDPI and ACS Style
Alfaifi, A.J.; Abdaly, A.Y.; Ghazwani, B.M.; Gosadi, I.M. Physicians’ Practices in Diabetic Nephropathy in Primary Healthcare Centers in Jazan City, Saudi Arabia, 2023. Medicina 2024, 60, 372. https://doi.org/10.3390/medicina60030372
AMA Style
Alfaifi AJ, Abdaly AY, Ghazwani BM, Gosadi IM. Physicians’ Practices in Diabetic Nephropathy in Primary Healthcare Centers in Jazan City, Saudi Arabia, 2023. Medicina. 2024; 60(3):372. https://doi.org/10.3390/medicina60030372
Chicago/Turabian StyleAlfaifi, Amal J., Ahmed Y. Abdaly, Bashaer M. Ghazwani, and Ibrahim M. Gosadi. 2024. "Physicians’ Practices in Diabetic Nephropathy in Primary Healthcare Centers in Jazan City, Saudi Arabia, 2023" Medicina 60, no. 3: 372. https://doi.org/10.3390/medicina60030372
